Vancouver-based HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) is set to start sending psilocybin mushrooms to a Jamaican cannabis producer to sell them in the country.
On Tuesday, the biotechnology announced it entered a supply agreement with Green Stripe Naturals Ltd. through its subsidiary Green Peak Growers Ltd. which is a licenced cannabis producer in Jamaica. Green Stripe will distribute the psilocybin for sale at licensed dispensaries given the country’s legality around psychedelic mushrooms.
Green Stripe was one of the first cannabis companies in Jamaica and is currently looking into distributing its psilocybin and cannabis products in 14 local dispensaries and anticipates the number to grow to 35 by the end of the year.
Green Stripe and HAVN Life are also exploring future collaborations, including expanded distribution into other Caribbean islands where cannabis and psilocybin-containing mushrooms are legal.
Havn Life’s operations in Jamaica are facilitated by strategic partnerships with Hypha Wellness and P.A. Benjamin Manufacturing Company to provide cultivation and processing facilities for psilocybin-containing mushrooms, strengthening its relationships with local partners.
Read more: Havn Life partners with non-profit TheraPsil to bring safe access to psilocybin
Read more: Havn wants to turn hard lessons into psychedelic gold
“We are very pleased to be partnering with Green Stripe Naturals, providing the highest quality standardized and naturally derived psilocybin containing mushrooms to their dispensary customers across Jamaica,” HAVN Life CEO Tim Moore said.
“We see many operational similarities between our two organizations and look forward to collaborating on building a network of trusted, plant-derived products to the Caribbean market and beyond,” he added.
Green Stripe CEO Wayne Isaacs said that partnering with HAVN provides his company with a premium source of psilocybin.
“And we are looking forward to working with their science and development teams to further enhance the product offering to serve both the retail and psilocybin retreat markets in Jamaica and the entire Caribbean region,” he said.
“This is a great opportunity to create unique and special products based on market demand and backed by top-tier science.”
